Amphastar Pharmaceuticals has a growth model based on organic growth and acquisitions, though competition and patent ...
James Hardie Industries plc (ASX / NYSE: JHX) ("James Hardie" or the "Company"), a leader in providing high performance, low maintenance building products and solutions, and a company inspiring how ...
Investing.com -- Glencore (LON: GLEN) shares slipped more than 5% on Wednesday after reporting 2024 EBITDA of $14.36 billion, ...
Welcome to the James Hardie Fiscal Third Quarter 2025 Earnings Conference Call. After prepared remarks by management, there ...
Atturra’s half yearly consolidated revenue for its 2025 financial year is expected to reach up to $142 million, an increase ...
Discover James Hardie's strong Q3 2025 results with 29% EBIT margins, key partnerships, and strategic growth plans.
JOST closes financial year 2024 successfully. Strong free cash flow of EUR +115 million paves the way for future growth. Sales guidance achieved: Sales of EUR 1,069.4 million (2023: EUR 1,249.7 ...
The most recent share buyback program was completed on February 29, 2024, and Outokumpu repurchased 8,357,545 shares during 2024. Outokumpu Board of Directors proposes that a dividend of EUR 0.26 per ...
Based in Switzerland, Bell Food Group reports year-on-year improvements in revenue and profitability for the 12 months just ...
Glencore is considering moving its primary listing from London, it said on Wednesday, after it posted lower earnings, ...
FEBRUARY 2025 AT 8:00 Eezy Plc's Financial Statements Bulletin 1-12/2024: Strategic actions are progressing, EBIT still on a modest level October-December ...